Form EFFECT OKYO Pharma Ltd
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | February 10, 2026 9:00 A.M. |
| Form: | F-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- OKYO Pharma to Participate in a Fireside Chat at the Cantor Global Healthcare Conference
- APPLEGATE SHARES NEW FINDINGS ON OMEGA FATTY ACIDS THROUGH REGENERATIVE HEALTH INITIATIVE
- DSS, Inc. Launches DSS Robotics to Bring AI-Powered Automation to Enterprise Operations
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
